The landscape of pharmaceutical innovation is constantly evolving, driven by the discovery and synthesis of new therapeutic agents. Central to this progress is the availability of high-quality chemical building blocks that form the foundation of these new drugs. 3-[1-(Dimethylamino)ethyl]phenol, identified by its CAS number 105601-04-5, is a prime example of such a critical intermediate. Its chemical structure and reactivity make it indispensable in the synthesis of important pharmaceuticals, most notably as a precursor to Rivastigmine.

The chemical properties of 3-[1-(Dimethylamino)ethyl]phenol, including its molecular formula C10H15NO and molecular weight of 165.23 g/mol, dictate its utility in advanced organic synthesis. As a pale brown solid, its physical state and solubility in various solvents are key considerations for chemists. Understanding these 'CAS 105601-04-5 chemical properties' allows for precise control over reaction conditions, leading to more efficient and higher-yield synthetic processes. This makes it an attractive compound for those looking to 'buy 3-[1-(Dimethylamino)ethyl]phenol online'.

Beyond its established use in Rivastigmine production, 3-[1-(Dimethylamino)ethyl]phenol also holds potential for further research and development in medicinal chemistry. Its phenolic and amino functionalities offer avenues for structural modification and the creation of novel compounds with potentially therapeutic benefits. Pharmaceutical companies and research institutions worldwide rely on dependable sources for such versatile building blocks. Chinese manufacturers, including NINGBO INNO PHARMCHEM CO., LTD., play a vital role in providing these essential materials, supporting the broader mission of pharmaceutical innovation.

The availability of high-purity intermediates like 3-[1-(Dimethylamino)ethyl]phenol from trusted pharmaceutical intermediate suppliers in China empowers researchers and manufacturers to push the boundaries of drug discovery and development. By providing the foundational chemistry, these suppliers enable the creation of next-generation therapeutics. The strategic sourcing of such compounds is a critical factor in the pace and success of pharmaceutical innovation.